hummmmmmmmmmmmmm
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
Published: Mar 20, 2024
MALVERN, Pa., March 20, 2024 (GLOBE NEWSWIRE) --Annovis Bio, Inc.(NYSE: ANVS), a clinical-stage drug platform company developing novel...